PAR-21-059 - Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
| Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders |
NOT-NS-22-010 |
NINDS
|
Oct 1, 2021 |
Jan 8, 2025
|
R61/R33, U01, U44 |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
